This story has been updated to include comments from Becton Dickinson.
NEW YORK (GenomeWeb) – A large evaluation of three commercial PCR-based methicillin-resistant Staphylococcus aureus assays has determined that the Roche LightCycler MRSA Advanced Test yields the highest economic return when used for universal patient screening.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.